Considering the results of previous studies showing increased concentration of IL-6 in some other inflammatory rheumatic diseases such as systemic lupus erythematosus, rheumatoid arthritis and systemic sclerosis, it is assumed that IL-6 could be an indicator of symptoms common to all inflammatory rheumatic diseases such as depression (18, 19). Here, IL6 is linked to systemic sclerosis.